Design Therapeutics, Inc. (DSGN)

Typically moves ±8.19% on earnings

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-11-06 ESTIMATED

Design Therapeutics, Inc. (DSGN) has reported earnings 22 times since May 10, 2021. The stock moves an average of ±8.19% the day after reporting, closing higher 54.5% of the time. Its largest post-earnings gain was +23.26% (Apr 28, 2026) and its largest decline was -70.46% (Aug 14, 2023). The next earnings report is predicted for 2026-11-06 (estimated).

Earnings reactions

How DSGN moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±8.19%

Positive %

54.5%

Negative %

45.5%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 03, 2026	☀ PRE	+4.97%	open_in_new
Apr 28, 2026	☽ POST	+23.26%	open_in_new
Mar 09, 2026	☽ POST	-3.66%	open_in_new
Nov 05, 2025	☽ POST	+4.89%	open_in_new
Aug 07, 2025	☽ POST	+7.81%	open_in_new
May 07, 2025	☽ POST	+5.71%	open_in_new
Mar 10, 2025	☀ PRE	-1.02%	open_in_new
Nov 07, 2024	☽ POST	+0.69%	open_in_new
Aug 05, 2024	☀ PRE	-1.69%	open_in_new
May 08, 2024	☽ POST	+1.71%	open_in_new
Mar 19, 2024	☽ POST	+11.97%	open_in_new
Nov 13, 2023	☽ POST	+11.71%	open_in_new
Aug 14, 2023	☽ POST	-70.46%	open_in_new
May 09, 2023	☽ POST	-11.66%	open_in_new
Mar 14, 2023	☽ POST	-0.85%	open_in_new
Nov 03, 2022	☽ POST	-0.19%	open_in_new
Aug 08, 2022	☽ POST	+2.66%	open_in_new
May 09, 2022	☽ POST	-0.36%	open_in_new
Mar 10, 2022	☽ POST	-1.82%	open_in_new
Nov 09, 2021	☽ POST	+0.11%	open_in_new
Aug 09, 2021	☽ POST	+6.19%	open_in_new
May 10, 2021	☽ POST	-6.82%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±8.19%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 21 →

Funds holding

$85415105

Total value held

Buying

17 added · 3 reduced

Blackrock, Inc.

$38490551 +24.66%

Morgan Stanley

$11075699 +16.58%

State Street Corp

$10653118 +11.62%

Goldman Sachs Group Inc

$9500771 +30.09%

Northern Trust Corp

$5110762 +17.62%

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G	20260814	open_in_new SEC.gov
10-Q	20260803	open_in_new SEC.gov
8-K	20260803	open_in_new SEC.gov
4	20260611	open_in_new SEC.gov
4	20260611	open_in_new SEC.gov
4	20260611	open_in_new SEC.gov
4	20260611	open_in_new SEC.gov
4	20260611	open_in_new SEC.gov
4	20260611	open_in_new SEC.gov

Frequently asked about DSGN earnings

When does Design Therapeutics, Inc. report earnings next? expand_more

Design Therapeutics, Inc. (DSGN)'s next earnings date is estimated for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does DSGN stock move after earnings? expand_more

Over 22 reports, DSGN has moved an average of ±8.19% the session after earnings, closing higher 54.5% of the time.

What was DSGN's biggest post-earnings move? expand_more

DSGN's largest post-earnings gain on record was +23.26% on Apr 28, 2026, and its largest decline was -70.46% on Aug 14, 2023.

Where can I find Design Therapeutics, Inc.'s SEC filings? expand_more

All of Design Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.